202 related articles for article (PubMed ID: 14722252)
1. Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins.
Kuwasako K; Cao YN; Nagoshi Y; Tsuruda T; Kitamura K; Eto T
Mol Pharmacol; 2004 Jan; 65(1):207-13. PubMed ID: 14722252
[TBL] [Abstract][Full Text] [Related]
2. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and kinetic characterization of adrenomedullin 1 and calcitonin gene-related peptide 1 receptor reporter cell lines.
Wunder F; Rebmann A; Geerts A; Kalthof B
Mol Pharmacol; 2008 Apr; 73(4):1235-43. PubMed ID: 18174292
[TBL] [Abstract][Full Text] [Related]
4. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
Zumpe ET; Tilakaratne N; Fraser NJ; Christopoulos G; Foord SM; Sexton PM
Biochem Biophys Res Commun; 2000 Jan; 267(1):368-72. PubMed ID: 10623626
[TBL] [Abstract][Full Text] [Related]
5. Assembly and signaling of CRLR and RAMP1 complexes assessed by BRET.
Héroux M; Breton B; Hogue M; Bouvier M
Biochemistry; 2007 Jun; 46(23):7022-33. PubMed ID: 17503773
[TBL] [Abstract][Full Text] [Related]
6. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
Thota C; Gangula PR; Dong YL; Yallampalli C
Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
[TBL] [Abstract][Full Text] [Related]
7. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
Udawela M; Christopoulos G; Morfis M; Christopoulos A; Ye S; Tilakaratne N; Sexton PM
Mol Pharmacol; 2006 Nov; 70(5):1750-60. PubMed ID: 16912219
[TBL] [Abstract][Full Text] [Related]
8. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.
McLatchie LM; Fraser NJ; Main MJ; Wise A; Brown J; Thompson N; Solari R; Lee MG; Foord SM
Nature; 1998 May; 393(6683):333-9. PubMed ID: 9620797
[TBL] [Abstract][Full Text] [Related]
9. [Increased atria expression of receptor activity-modifying proteins in heart failure patients].
Wang YF; Zhang J; Li J; Lan LQ; Yang ZM; Wang SR
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):351-4. PubMed ID: 15300632
[TBL] [Abstract][Full Text] [Related]
10. Female sex steroid hormones and pregnancy regulate receptors for calcitonin gene-related peptide in rat mesenteric arteries, but not in aorta.
Yallampalli C; Kondapaka SB; Lanlua P; Wimalawansa SJ; Gangula PR
Biol Reprod; 2004 Apr; 70(4):1055-62. PubMed ID: 14668209
[TBL] [Abstract][Full Text] [Related]
11. Expression of calcitonin gene-related peptide type 1 receptor mRNA and their activity-modifying proteins in the rat nucleus accumbens.
Li N; Fang CY; Wang ZZ; Wang YL; Wang FB; Gao E; Zhang GX
Neurosci Lett; 2004 May; 362(2):146-9. PubMed ID: 15193773
[TBL] [Abstract][Full Text] [Related]
12. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.
Udawela M; Christopoulos G; Tilakaratne N; Christopoulos A; Albiston A; Sexton PM
Mol Pharmacol; 2006 Jun; 69(6):1984-9. PubMed ID: 16531504
[TBL] [Abstract][Full Text] [Related]
13. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.
Tilakaratne N; Christopoulos G; Zumpe ET; Foord SM; Sexton PM
J Pharmacol Exp Ther; 2000 Jul; 294(1):61-72. PubMed ID: 10871296
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of the calcitonin receptor-like receptor domains responsible for cell-surface translocation of receptor activity-modifying proteins.
Kuwasako K; Kitamura K; Nagata S; Kato J
Biochem Biophys Res Commun; 2009 Jun; 384(2):249-54. PubMed ID: 19394311
[TBL] [Abstract][Full Text] [Related]
15. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
Salvatore CA; Mallee JJ; Bell IM; Zartman CB; Williams TM; Koblan KS; Kane SA
Biochemistry; 2006 Feb; 45(6):1881-7. PubMed ID: 16460034
[TBL] [Abstract][Full Text] [Related]
16. Receptor pharmacology.
Young A
Adv Pharmacol; 2005; 52():47-65. PubMed ID: 16492540
[TBL] [Abstract][Full Text] [Related]
17. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
Naot D; Cornish J
Bone; 2008 Nov; 43(5):813-8. PubMed ID: 18687416
[TBL] [Abstract][Full Text] [Related]
18. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
[TBL] [Abstract][Full Text] [Related]
19. Antiapoptotic effect of calcitonin gene-related peptide on oxidative stress-induced injury in H9c2 cardiomyocytes via the RAMP1/CRLR complex.
Sueur S; Pesant M; Rochette L; Connat JL
J Mol Cell Cardiol; 2005 Dec; 39(6):955-63. PubMed ID: 16242145
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of calcitonin receptor-like receptor and receptor activity-modifying protein 2 or 3 mediates the antimigratory effect of adrenomedullin.
Fukai N; Shichiri M; Ozawa N; Matsushita M; Hirata Y
Endocrinology; 2003 Feb; 144(2):447-53. PubMed ID: 12538603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
